Francesco Marangoni

Author PubWeight™ 13.49^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	HIV-infected T cells are migratory vehicles for viral dissemination.	Nature	2012	3.57
2	Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome.	Blood	2009	1.89
3	Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients.	J Immunol	2006	1.44
4	Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction.	J Clin Invest	2014	1.13
5	Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.	Mol Ther	2004	1.06
6	The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.	J Exp Med	2009	1.06
7	Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.	Hum Gene Ther	2006	1.03
8	Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.	J Allergy Clin Immunol	2010	0.92
9	Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12.	Int J Cancer	2003	0.88
10	CD44 keeps tumor killers polarized.	Immunity	2008	0.77
11	Current understanding of the Wiskott-Aldrich syndrome and prospects for gene therapy.	Expert Rev Clin Immunol	2007	0.75
12	Corrigendum to "Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models".	Mol Ther	2016	0.75